Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Long-term Depression01:05

Long-term Depression

31.3K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
31.3K
Depression: Overview01:18

Depression: Overview

327
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
327
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

319
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
319
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

202
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
202
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

162
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
162
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

715
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
715

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The experience of community-based peer support groups for people living with bipolar disorder: A qualitative focus group study.

Journal of affective disorders·2026
Same author

"Creation involved a lot of inspiration which drove me to create, and the creation was a record of myself at different moments": a nine-month photovoice study of creative practices and recovery from bipolar disorder.

BMC psychiatry·2026
Same author

Alignment of Lived Experience Questions with the Medical Literature in Bipolar Disorder: A Topic Modelling Approach: Adéquation entre les questions relatives à l'expérience vécue et la littérature médicale concernant le trouble bipolaire : Une approche de modélisation de sujets.

Canadian journal of psychiatry. Revue canadienne de psychiatrie·2026
Same author

Structured Online Support to Inform and Assist Antidepressant Deprescribing in Primary Care: Protocol for a Pragmatic, Randomized Controlled Trial (The WiserAD Trial).

JMIR research protocols·2026
Same author

Cultural Adaptation of a Digital Mobile App for Bipolar Disorder (PolarUs): Protocol for a Qualitative Co-Design Study.

JMIR research protocols·2026
Same author

5 Years of bipolar disorder conversations on Reddit: Methods, key topics and future directions.

PloS one·2026

Related Experiment Video

Updated: Sep 3, 2025

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

170

Mobile Health Applications for Depression in China: A Systematic Review.

Leping Huang1, Victor W Li2, Tao Yang3

  • 1Psychiatry, Hongkou Mental Health Centre, Shanghai, CHN.

Cureus
|July 29, 2022
PubMed
Summary
This summary is machine-generated.

Mobile health (mHealth) apps show promise for depression care in China, but rigorous evaluations are limited. While studies report benefits, high risk of bias necessitates further research into efficacy and acceptability.

Keywords:
chinadepressionmhealthmobile healthsmartphonessystematic reviewwechat

More Related Videos

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

28.8K
Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
05:35

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Published on: January 19, 2024

900

Related Experiment Videos

Last Updated: Sep 3, 2025

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

170
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

28.8K
Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
05:35

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Published on: January 19, 2024

900

Area of Science:

  • Digital Health
  • Mental Health Technology
  • Psychiatry

Background:

  • Mobile health (mHealth) applications offer potential to improve access to mental health services.
  • There is increasing interest in utilizing mHealth apps for depression management within China.

Purpose of the Study:

  • To systematically review existing research on mHealth applications for depression in China.
  • To identify the benefits and challenges associated with mHealth interventions for depression in the Chinese context.

Main Methods:

  • A systematic literature search was performed using both Chinese and English databases.
  • Studies included randomized and nonrandomized clinical trials evaluating mHealth apps for depression in China.
  • Study quality was assessed using the Cochrane Risk of Bias tool, adhering to PRISMA guidelines.

Main Results:

  • Seven studies met the inclusion criteria, primarily utilizing the WeChat platform for interventions.
  • Interventions included psychoeducation, self-management, supervised group chats, and remote healthcare team contact.
  • All studies reported significant benefits compared to usual care, but exhibited a high risk of bias.

Conclusions:

  • Current research on mHealth apps for depression in China is limited, with few rigorous evaluations.
  • While promising, the significant benefits observed are tempered by a high risk of bias, rendering results inconclusive.
  • Further research is needed to address efficacy, scalability, acceptability, and data privacy concerns for widespread adoption.